Gut microbial and short-chain fatty acid profiles in adults with chronic constipation before and after treatment with lubiprostone.

[1]  E. Quigley,et al.  CALL FOR PAPERS NextGen Sequencing Technology-Based Dissection of Physiological Systems Structural changes in the gut microbiome of constipated patients , 2014 .

[2]  Joshua LaBaer,et al.  Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children , 2013, PloS one.

[3]  Myung-Gyu Choi,et al.  Breath methane positivity is more common and higher in patients with objectively proven delayed transit constipation , 2013, European journal of gastroenterology & hepatology.

[4]  L. Ursell,et al.  Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. , 2013, Gastroenterology.

[5]  P. Moayyedi,et al.  Peripheral mechanisms in irritable bowel syndrome. , 2013, The New England journal of medicine.

[6]  S. Colgan.  Swimming Through the Gut: Implications of Fluid Transport on the Microbiome , 2013, Digestive Diseases and Sciences.

[7]  Yunwei Wang,et al.  Lubiprostone Decreases Mouse Colonic Inner Mucus Layer Thickness and Alters Intestinal Microbiota , 2013, Digestive Diseases and Sciences.

[8]  P. Turnbaugh,et al.  Xenobiotics Shape the Physiology and Gene Expression of the Active Human Gut Microbiome , 2013, Cell.

[9]  R. Gunsalus,et al.  Methanogens in Human Health and Disease , 2012 .

[10]  R. Gunsalus,et al.  Methanobrevibacter smithii Is the Predominant Methanogen in Patients with Constipation-Predominant IBS and Methane on Breath , 2012, Digestive Diseases and Sciences.

[11]  J. Harris,et al.  Activated fluid transport regulates bacterial-epithelial interactions and significantly shifts the murine colonic microbiome , 2012, Gut microbes.

[12]  Mehrdad Hajibabaei,et al.  Next‐generation sequencing technologies for environmental DNA research , 2012, Molecular ecology.

[13]  A. Eschalier,et al.  Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndrome , 2012, Alimentary pharmacology & therapeutics.

[14]  A. Ford,et al.  Prevalence of, and Risk Factors for, Chronic Idiopathic Constipation in the Community: Systematic Review and Meta-analysis , 2011, The American Journal of Gastroenterology.

[15]  Anne Salonen,et al.  Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. , 2010, Microbiology.

[16]  Robert C. Edgar,et al.  Search and clustering orders of magnitude faster than BLAST , 2010, Bioinform..

[17]  R. D. De Lisle,et al.  Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype , 2010, BMC gastroenterology.

[18]  S. Massart,et al.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa , 2010, Proceedings of the National Academy of Sciences.

[19]  Nathalie M. Delzenne,et al.  Prebiotic effects: metabolic and health benefits , 2010, British Journal of Nutrition.

[20]  M. Pimentel,et al.  Methane and the Gastrointestinal Tract , 2010, Digestive Diseases and Sciences.

[21]  L. Cobiac,et al.  Butyrylated starch increases large bowel butyrate levels and lowers colonic smooth muscle contractility in rats. , 2010, Nutrition research.

[22]  M. Jackson,et al.  Methanogenic Flora Is Associated With Altered Colonic Transit but Not Stool Characteristics in Constipation Without IBS , 2010, The American Journal of Gastroenterology.

[23]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[24]  P. de Coppet,et al.  Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. , 2010, Gastroenterology.

[25]  D. Drossman,et al.  Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation , 2010, Digestive Diseases and Sciences.

[26]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[27]  Rob Knight,et al.  PyNAST: a flexible tool for aligning sequences to a template alignment , 2009, Bioinform..

[28]  J. Escher,et al.  Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. , 2009, Gastroenterology.

[29]  Bruce E. Rittmann,et al.  Syntrophic interactions among anode respiring bacteria (ARB) and Non‐ARB in a biofilm anode: electron balances , 2009, Biotechnology and bioengineering.

[30]  Adam P. Arkin,et al.  FastTree: Computing Large Minimum Evolution Trees with Profiles instead of a Distance Matrix , 2009, Molecular biology and evolution.

[31]  W. Chey,et al.  Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome – results of two randomized, placebo‐controlled studies , 2009, Alimentary pharmacology & therapeutics.

[32]  Rolf U. Halden,et al.  Pre-genomic, genomic and post-genomic study of microbial communities involved in bioenergy , 2008, Nature Reviews Microbiology.

[33]  Michael P. Jones,et al.  Lactulose Breath Testing Does Not Discriminate Patients With Irritable Bowel Syndrome From Healthy Controls , 2008, The American Journal of Gastroenterology.

[34]  J. Johanson,et al.  Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Lubiprostone, a Locally-Acting Type-2 Chloride Channel Activator, in Patients With Chronic Constipation , 2008, The American Journal of Gastroenterology.

[35]  V. Lingala,et al.  Use of health care resources and cost of care for adults with constipation. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[37]  J. Johanson,et al.  Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double‐blind, placebo‐controlled, dose‐ranging study to evaluate efficacy and safety , 2007, Alimentary pharmacology & therapeutics.

[38]  B. Lacy,et al.  Lubiprostone: a chloride channel activator. , 2007, Journal of clinical gastroenterology.

[39]  Soumya Chatterjee,et al.  The Degree of Breath Methane Production in IBS Correlates With the Severity of Constipation , 2007, The American Journal of Gastroenterology.

[40]  W. Shehee,et al.  The relationship between the effects of short‐chain fatty acids on intestinal motility in vitro and GPR43 receptor activation , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[41]  Henry C. Lin,et al.  Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[42]  Marti J. Anderson,et al.  Distance‐Based Tests for Homogeneity of Multivariate Dispersions , 2006, Biometrics.

[43]  Eoin L. Brodie,et al.  Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.

[44]  M. Kuskowski,et al.  Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[45]  R. Knight,et al.  UniFrac: a New Phylogenetic Method for Comparing Microbial Communities , 2005, Applied and Environmental Microbiology.

[46]  E. Quigley,et al.  Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[47]  R. Mitsui,et al.  Neural and non‐neural mediation of propionate‐induced contractile responses in the rat distal colon , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[48]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.

[49]  M. B. de Morais,et al.  Breath Methane Associated With Slow Colonic Transit Time in Children With Chronic Constipation , 2005, Journal of clinical gastroenterology.

[50]  J. Penders,et al.  Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. , 2005, FEMS microbiology letters.

[51]  Michael Camilleri,et al.  Chronic constipation. , 2003, The New England journal of medicine.

[52]  M. Fujimiya,et al.  Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[53]  P. Hugenholtz.  Exploring prokaryotic diversity in the genomic era , 2002, Genome Biology.

[54]  C. Bouley,et al.  Effects of Consumptionof a Milk Fermented by the Probiotic Strain Bifidobacterium animalis DN-173 010 on Colonic Transit Times in Healthy Humans , 2001 .

[55]  Marti J. Anderson,et al.  A new method for non-parametric multivariate analysis of variance in ecology , 2001 .

[56]  Hsiao‐ling Chen,et al.  Effects of fructooligosaccharide on bowel function and indicators of nutritional status in constipated elderly men , 2000 .

[57]  J. Galmiche,et al.  Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[58]  G. Zoppi,et al.  The intestinal ecosystem in chronic functional constipation , 1998, Acta paediatrica.

[59]  G. Macfarlane,et al.  Validation of a Three-Stage Compound Continuous Culture System for Investigating the Effect of Retention Time on the Ecology and Metabolism of Bacteria in the Human Colon , 1998, Microbial Ecology.

[60]  S. Lewis,et al.  Stool form scale as a useful guide to intestinal transit time. , 1997, Scandinavian journal of gastroenterology.

[61]  D. Drossman,et al.  Functional Bowel Disorders , 1995, The American Journal of Gastroenterology.

[62]  K. Burgio,et al.  Constipation in the Elderly: Influence of Dietary, Psychological, and Physiological Factors , 1994, Journal of the American Geriatrics Society.

[63]  B. Drasar,et al.  Breath methane excretion and intestinal methanogenesis in children and adults in rural Nigeria. , 1993, Scandinavian journal of gastroenterology.

[64]  K. R. Clarke,et al.  Non‐parametric multivariate analyses of changes in community structure , 1993 .

[65]  N. Read,et al.  Effect of short-chain fatty acids on contractile activity and fluid flow in rat colon in vitro. , 1992, The American journal of physiology.

[66]  H. Binder,et al.  Short-chain fatty acids stimulate active sodium and chloride absorption in vitro in the rat distal colon. , 1989, Gastroenterology.

[67]  Zarling Ej,et al.  Protein origin of the volatile fatty acids isobutyrate and isovalerate in human stool. , 1987 .

[68]  A. Anderson.  Dietary factors in the aetiology and treatment of constipation during pregnancy , 1986, British journal of obstetrics and gynaecology.

[69]  T. Yajima.  Contractile effect of short‐chain fatty acids on the isolated colon of the rat. , 1985, The Journal of physiology.

[70]  J. Bond,et al.  FACTORS INFLUENCING PULMONARY METHANE EXCRETION IN MAN , 1971, The Journal of experimental medicine.

[71]  C. E. SHANNON,et al.  A mathematical theory of communication , 1948, MOCO.

[72]  S. Dowd,et al.  Tag-encoded FLX amplicon pyrosequencing for the elucidation of microbial and functional gene diversity in any environment. , 2011, Methods in molecular biology.

[73]  M. Metzker.  Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.

[74]  M. Crowell,et al.  Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation. , 2007, Current opinion in investigational drugs.

[75]  F. Mion,et al.  Impact of anal incontinence and chronic constipation on quality of life. , 2004, Gastroenterologie clinique et biologique.

[76]  Brian H. McArdle,et al.  FITTING MULTIVARIATE MODELS TO COMMUNITY DATA: A COMMENT ON DISTANCE‐BASED REDUNDANCY ANALYSIS , 2001 .

[77]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[78]  D. Faith.  Conservation evaluation and phylogenetic diversity , 1992 .

[79]  A. Chao.  Nonparametric estimation of the number of classes in a population , 1984 .

[80]  Kenneth J. Berry,et al.  Multi-response permutation procedures for a priori classifications , 1976 .

[81]  E. H. Simpson.  Measurement of Diversity , 1949, Nature.